相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease
Kanta Horie et al.
BRAIN (2021)
Structure-based classification of tauopathies
Yang Shi et al.
NATURE (2021)
Donanemab in Early Alzheimer's Disease
Mark A. Mintun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody
Chad J. Swanson et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Stephen Salloway et al.
NATURE MEDICINE (2021)
MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
Chihiro Sato et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease
Kanta Horie et al.
BRAIN (2021)
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
Toji Miyagawa et al.
ALZHEIMERS & DEMENTIA (2020)
Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology
Kaj Blennow et al.
BRAIN (2020)
Novel tau filament fold in corticobasal degeneration
Wenjuan Zhang et al.
NATURE (2020)
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Shorena Janelidze et al.
NATURE MEDICINE (2020)
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
Elisabeth H. Thijssen et al.
NATURE MEDICINE (2020)
Distribution patterns of tau pathology in progressive supranuclear palsy
Gabor G. Kovacs et al.
ACTA NEUROPATHOLOGICA (2020)
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease
Shorena Janelidze et al.
NATURE COMMUNICATIONS (2020)
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification
Nicolas R. Barthelemy et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease
Nicolas R. Barthelemy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
Kanta Horie et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules
Benjamin Falcon et al.
NATURE (2019)
Biomarkers for tau pathology
Michael Scholl et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
Victor L. Villemagne et al.
NATURE REVIEWS NEUROLOGY (2018)
Tau Kinetics in Neurons and the Human Central Nervous System
Chihiro Sato et al.
NEURON (2018)
Structures of filaments from Pick's disease reveal a novel tau protein fold
Benjamin Falcon et al.
NATURE (2018)
Cryo-EM structures of tau filaments from Alzheimer's disease
Anthony W. P. Fitzpatrick et al.
NATURE (2017)
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod et al.
ALZHEIMERS & DEMENTIA (2017)
Ante Mortem Cerebrospinal Fluid Tau Levels Correlate With Postmortem Tau Pathology in Frontotemporal Lobar Degeneration
David J. Irwin et al.
ANNALS OF NEUROLOGY (2017)
Clinical Approach to Progressive Supranuclear Palsy
Helen Ling
JOURNAL OF MOVEMENT DISORDERS (2016)
Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy
Dana Wagshal et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
Barbara Borroni et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2015)
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP
William T. Hu et al.
NEUROLOGY (2013)
Corticobasal degeneration: a pathologically distinct 4R tauopathy
Naomi Kouri et al.
NATURE REVIEWS NEUROLOGY (2011)
Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho-Tau in patients with low- and high-CSF Aβ40 load
Jens Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Argyrophilic grain disease is a sporadic 4-repeat tauopathy
T Togo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
分享论文
